Searchable abstracts of presentations at key conferences in endocrinology

ea0063ep150 | Thyroid | ECE2019

Mixed histiocytosis with BRAF (V600E) mutation and papillary thyroid carcinoma

Archambeaud Francoise , Vital Pauline , Russ Gilles , Pommepuy Isabelle , Haroche Julien , Valleix Denis , Bourras Jean Charles , Nassouri Sika , Parreau Simon

Langherhans cell histiocytosis (LCH) and Erdheim-Chester (EC) are two histiocytic disorders which occurrence in the same patient has rarely been described. Thyroid involvement of LCH is rare, and concurrent papillary thyroid carcinoma (PTC) exceptionally reported. We report a case of a 73 year old man who presented a diagnosis of mixed histiocytosis LCH and EC. The patient suffered of insipidus diabetes since 1 year without pituitary abnormality but clinical examination showed...

ea0073aep695 | Thyroid | ECE2021

-Systemic erdheim-chester disease associated with braf-positive papillary thyroid carcinoma

Ilie Iuliana , Francois Emile Jean , Chereau Natalie , Haroche Julien , Buffet Camille , Deniziaut Gabrielle , Constantin Teodor , Bercu Bogdan , Oprea Luciana , Banica Andreea , Musat Madalina

Erdheim-Chester disease (ECD) is a rare histiocytic neoplasm with distinctive clinical and immunophenotypic features, involving somatic mutations of BRAF and activation of MAPK pathway. Other BRAF mutated neoplasms such as papillary thyroid carcinoma (PTC), may also occur synchronous with EDC. There are several reports in the literature of concurrent Langerhans Cell Histiocytosis (LCH) and PTC which suggests that the association is not random, howeve...